Welcome to CRC

Press Releases

CR Double-Crane became sole developer, manufacturer and distributor of Novita Pharmaceuticals' new anti-tumor drug in Greater China

CR Double-Crane Pharmaceuticals Co., Ltd (“CR Double-Crane”) announced that it was authorized solely to develop, manufacture and commercialize Novita Pharmaceuticals, Inc.’s (“Novita Pharmaceuticals”) new target Fascin protein inhibitor NP-G2-044 in the Greater China Region (Mainland China, Hong Kong, Macau and Taiwan) on 21 July. An online signing ceremony was held on the same day.

07/22/2021
CR Pharmaceutical met with the delegation from Democratic Republic of Congo

On 8 July 2021, the delegation led by First Secretary of the Embassy of the Democratic Republic of the Congo in China Jock visited CR Pharmaceutical Holdings (“CR Pharma”) to exchange views and ideas on diagnostic reagents export business, and to understand CR Pharma’s diagnostic reagent business as well as its capability to export products so as to lay the foundation for mutually beneficial collaboration in future.

07/21/2021
CY Leung attended the unveiling ceremony of the cooperation between HKCCC and RUN HK

On 3 November 2020, Guangxi China Resources Building, a new landmark in Guangxi meticulously built by China Resources Land (“CR Land”), was officially completed. On the same day, the RUN HK Guangxi-Hong Kong Industrial Innovation Centre and the Hong Kong Youth (Mainland) Entrepreneurship Service Centre held an unveiling ceremony in the Guangxi China Resources Building where both centres are housed. CY Leung, Vice Chairman of the National Committee of the Chinese People'...

11/04/2020
Kick-off of the China Resources "Healthy Village" charity project

On 5 September 2020, in celebration of the fifth Charity Day of China, China Resources launched the "Healthy Village" philanthropic initiative with the theme of "Caring for Primary Health and Building a Healthy China" in Beijing. Adhering to the "Healthy China 2030 Planning Outline" and "China Women (and Children) Development Outline", the project aims to implement the rural revitalization strategy.

09/07/2020
CR Power becomes a constituent in the HSI ESG 50 Index and Hang Seng Corporate Sustainability Benchmark Index

Hang Seng Indexes Company Limited (“Hang Seng Indexes”) recently announced the results of its review of the Hang Seng Family of Indexes for the quarter ended 30 June 2020. For the first time, CR Power is included as a constituent in both the HSI ESG 50 Index and Hang Seng Corporate Sustainability Benchmark Index.

08/24/2020
CR Power Ranked 7th in the Greater Bay Area Business Sustainability Index

CR Power was ranked 7th as a Pace-Setter among 67 companies in the first Greater Bay Area Business Sustainability Index (“GBABSI”) jointly launched by the Chinese University of Hong Kong (“CUHK”) Business School’s Centre for Business Sustainability (“CBS”), CUHK and SGS Hong Kong on 24 July 2020.

07/28/2020
CR Land is Selected as One of the Best Performing Constituents in HSI ESG Index

Hang Seng Indexes Company Limited (“Hang Seng Indexes”) has recently launched the HSI ESG 50 Index to reflect the performance of top 50 ESG leaders with relatively high market-capitalization listed in Hong Kong. CR Land is included in the ESG 50 Index based on a comprehensive assessment of its ESG performance by Hang Seng Indexes.

07/09/2020
Runfeng Cement’s 2020 Brand Value Exceeds RMB50 billion

On 28 June 2020, CR Cement announced the brand valuation report presented by the World Brand Lab on its proprietary brand Runfeng Cement. According to the report, Runfeng Cement’s 2020 brand value reached RMB51.958 billion.

06/29/2020
Grand Opening of CR Capital Tower

On 27 May 2020, CR Capital and CR Land jointly organized the unveiling ceremony for CR Capital Tower in Shenzhen with China Resources Group General Manager Wang Xiangming officiating at the ceremony.

05/27/2020
CR Gas raised HK$3.67 billion through share placement

On 12 May 2020, CR Gas announced to place a total of 90 million shares at a price of HK$40.81 per share in the capital market through placing of existing shares and top-up subscription for new shares. The placing price represented a 7.14% discount to the closing price in the last trading day of the announcement and a 4.69% discount to average closing price of the past 5 trading days. The shares placed represented approximately 4.05% of the issued share capital of the Company...

05/12/2020